Detailed Information on Publication Record
2016
Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma
TICHÝ, Michal, Lucia KNOPFOVÁ, Jiří JARKOVSKÝ, Lucie PEKARČÍKOVÁ, Lenka VEVERKOVÁ et. al.Basic information
Original name
Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma
Authors
TICHÝ, Michal (203 Czech Republic, belonging to the institution), Lucia KNOPFOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Lucie PEKARČÍKOVÁ (203 Czech Republic, belonging to the institution), Lenka VEVERKOVÁ (203 Czech Republic), Petr VLČEK (203 Czech Republic), Jana KATOLICKÁ (203 Czech Republic), Ivan ČAPOV (203 Czech Republic), Markéta HERMANOVÁ (203 Czech Republic, belonging to the institution), Jan ŠMARDA (203 Czech Republic, belonging to the institution) and Petr BENEŠ (203 Czech Republic, guarantor, belonging to the institution)
Edition
Tumor Biology, Springer Netherlands, 2016, 1010-4283
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10601 Cell biology
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 3.650
RIV identification code
RIV/00216224:14310/16:00088876
Organization unit
Faculty of Science
UT WoS
000382672900072
Keywords (in Czech)
c-Myb; kolorektální karcinom; imunohistochemie; metastázy; mRNA
Keywords in English
c-Myb; colorectal carcinoma; immunohistochemistry; metastases; mRNA
Tags
International impact, Reviewed
Změněno: 19/2/2018 10:01, doc. Mgr. Petr Beneš, Ph.D.
Abstract
V originále
The MYB gene codes for the c-Myb transcription factor maintaining proliferation of colon epithelial progenitors, thus controlling colon development and homeostasis. This gene is overexpressed in early phases of colorectal cancer (CRC) tumorigenesis. The aim of this study was to examine the expression of c-Myb in CRC tissue samples both at the messenger RNA (mRNA) and protein levels and to evaluate their associations with clinicopathological characteristics in a group of 108 CRC patients. Statistically significant negative association was found between the frequency of the c-Myb-positive tumor cells assessed by immunohistochemistry and the presence of distant metastases but not tumor differentiation, tumor stage, lymph node involvement, vascular invasion, tumor localization, age, and gender of the patients. Although the c-Myb protein level in the tumor tissue correlated with its mRNA level, no significant association between MYB mRNA and any clinicopathological characteristics was observed. We conclude that albeit overexpression of c-Myb is considered as an important factor contributing to early phases of CRC tumorigenesis, it may later have negative effect on tumor cell dissemination as observed recently in breast cancer as well. Further studies are required to explain the role of c-Myb during formation of CRC distant metastases.
Links
NT13441, research and development project |
|